Hidetoshi Hayashi
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 5%
- Cancer Research top 2%
- Immunology top 5%
- Co-authors
- Kazuhiko NakagawaMasayuki TakedaKaoru TanakaKoji HarataniKazuto NishioKimio YonesakaYasutaka ChibaHiroyasu Kaneda
- Topics
- Lung Cancer Treatments and Mutations (156 papers)Lung Cancer Research Studies (72 papers)Colorectal Cancer Treatments and Studies (45 papers)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Hidetoshi Hayashi
230 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 3.7k
- Pulmonary and Respiratory Medicine 2.8k
- Molecular Biology 1.4k
- Cancer Research 705
- Immunology 488
Countries citing papers authored by Hidetoshi Hayashi
This map shows the geographic impact of Hidetoshi Hayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetoshi Hayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetoshi Hayashi more than expected).
Fields of papers citing papers by Hidetoshi Hayashi
This network shows the impact of papers produced by Hidetoshi Hayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetoshi Hayashi. The network helps show where Hidetoshi Hayashi may publish in the future.
Co-authorship network of co-authors of Hidetoshi Hayashi
This figure shows the co-authorship network connecting the top 25 collaborators of Hidetoshi Hayashi. A scholar is included among the top collaborators of Hidetoshi Hayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetoshi Hayashi. Hidetoshi Hayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 4 | |
| 11 | 22 | |
| 12 | 66 | |
| 13 | 172 | |
| 14 | 13 | |
| 15 | 15 | |
| 16 | 16 | |
| 17 | 126 | |
| 18 | 2 | |
| 19 | 1 | |
| 20 | [In vitro sensitivity test of anti-neoplastic agents and their enhancement by biscoclaurine alkaloid]. | 1 |
About Hidetoshi Hayashi
Hidetoshi Hayashi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 248 papers that have together received 5.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (156 papers), Lung Cancer Research Studies (72 papers) and Colorectal Cancer Treatments and Studies (45 papers). The work is most often cited by research in Oncology (3.7k citations), Pulmonary and Respiratory Medicine (2.8k citations) and Cancer Research (705 citations). Hidetoshi Hayashi has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Kazuhiko Nakagawa, Masayuki Takeda, Kaoru Tanaka, Koji Haratani, Kazuto Nishio, Kimio Yonesaka, Yasutaka Chiba, Hiroyasu Kaneda, Ryoji Kato and Kazuko Sakai. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.